Selection for protease inhibitors using bacteriophage display.
Markland
W
W
Vertex Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA.
Roberts
B L
BL
Ladner
R C
RC
D000595:Amino Acid Sequence; D001435:Bacteriophages / Q000235:genetics*; D001483:Base Sequence; D003090:Coliphages / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics / Q000821:virology; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D014644:Genetic Variation; D005822:Genetic Vectors; D006801:Humans; D017912:Inovirus / Q000235:genetics; D007610:Kallikreins / Q000037:antagonists & inhibitors; D008074:Lipoproteins / Q000235:genetics*; D008969:Molecular Sequence Data; D012441:Saccharomyces cerevisiae / Q000235:genetics; D012641:Selection, Genetic; D015842:Serine Proteinase Inhibitors / Q000235:genetics*; D013917:Thrombin / Q000037:antagonists & inhibitors
D008074:Lipoproteins; D015842:Serine Proteinase Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D007610:Kallikreins; D013917:Thrombin; D005341:Fibrinolysin